$MEDS

DataMeds AI, Inc.

Nasdaq · Services · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Tampa, FL

MEDS chart

What traders are saying about $MEDS

Latest posts

DataMeds AI, Inc. news

DataMeds AI, Inc. key financials

USD202520242023
Revenue$23.3M$18.1M–
Net income-$101.3M-$6.9M-$2.9M
Diluted EPS$-1.43$-0.15$-0.06
Total assets (year end)$30.5M$57.3M$338,364
Cash and equivalents (year end)$42,571$1.0M$1,364

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • S-1S-1
  • 8-K8-K
  • 8-K8-K

About DataMeds AI, Inc.

Ticker
MEDS (Nasdaq)
Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries
Headquarters
Tampa, FL
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
2030763
Former names
Wellgistics Health, Inc., Danam Health, Inc

Frequently asked questions

What exchange is DataMeds AI, Inc. listed on?

DataMeds AI, Inc. trades on the Nasdaq under the ticker symbol MEDS.

What industry is DataMeds AI, Inc. in?

DataMeds AI, Inc. is classified by the SEC under "Wholesale-Drugs, Proprietaries & Druggists' Sundries", part of the Services sector on StockTweeting.

Where is DataMeds AI, Inc. headquartered?

DataMeds AI, Inc.'s business address on file with the SEC is in Tampa, FL.

When does DataMeds AI, Inc.'s fiscal year end?

DataMeds AI, Inc.'s fiscal year ends on December 31.

How much revenue did DataMeds AI, Inc. report?

DataMeds AI, Inc. reported $23.3M in revenue for calendar year 2025, according to its SEC filings.